BN Business News
Add your company to Business Communicator →

Regulation & law · 26/11/2019

National Institutes of Health to Grant Exclusive Patent License for Gene Therapy for Ocular Disease

The National Institutes of Health is considering granting an exclusive patent license to OcQuila Therapeutics Ltd. for using the inventions covered by a specific patent, related to gene therapy for ocular diseases.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights